#USA #Cincinnati #gene therapy #Cincinnati Children's #hearing restoration

In a groundbreaking clinical trial at Cincinnati Children's Hospital, experts have successfully rehabilitated the hearing of children suffering from inherited deafness through a one-time gene therapy known as Otarmeni (lunsotogene parvec-cwha). The trials showed remarkable outcomes, particularly for siblings Abdu and Sumaya, who were both able to hear sounds within weeks of receiving the treatment. The therapy aims specifically to address profound sensorineural hearing loss linked to genetic variants in the OTOF gene, allowing many children to hear naturally without the reliance on traditional hearing devices. The clinical approach refers closely to cochlear implant procedures but involves the direct infusion of the therapy, which helps amplify natural hearing capabilities. The results have been impressive; by the 24-week mark, nine out of 12 initial participants were able to discern sounds that are generally audible without cochlear implants, with some achieving normal hearing levels. Despite challenges in targeting various genetic dysfunctions, the initial findings highlight a promising future for creating custom therapies suited for individual cases. As further studies are carried out, many families hold hope that the potential of this therapy can expand to cover a broader range of genetic hearing loss causes. With this trial, the researchers believe it's crucial to redefine potential treatment windows beyond infancy, offering new possibilities for older children who previously had limited options. The ongoing research underpins the importance of understanding genetic disorders and innovating treatments that can make dramatic differences in the lives of children affected by hearing issues. John Greinwald Jr., MD, emphasizes the significance of these advancements, stating that this could be the start of new endeavors in molecular intra-cochlear therapy, paving the way for improved treatment approaches for many more children in the future. As more results are expected to emerge, Cincinnati Children's Hospital remains at the forefront of scientific innovation, hoping to further advance health solutions for the next generation.